| Product | Rights Territory* | Indications | Clinical Trial Approval |
Pivotal Clinical Trial | Marketing Application | Marketed | Key Approved Regions* | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| China | US | Europe | Japan | Other | |||||||
| Cefcapene Pivoxil Hydrochloride Granules |  |
Pediatric Infection |
√ |
√ |
|||||||
| Cefazolin Powder and Solution Dual-Chamber Bag for Injection |  |
Anti-infection |
√ |
√ |
|||||||
| Compound Toad Venom Plaster |  |
Pain |
√ |
||||||||
| Product | Rights Territory* | Indications | Clinical Trial Approval |
Pivotal Clinical Trial | Marketing Application | Marketed | Key Approved Regions* | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| China | US | Europe | Japan | Other | |||||||
| HWS0101 |  |
Chronic venous leg ulcers unresponsive to standard care and compression therapy | √ |
||||||||
| HWX0101 | |
Initial treatment and long-term management of adult hypertension; prevention of hemorrhagic stroke (ICH) recurrence | √ |
||||||||
| HWY0201 | |
IUD placement and removal, uterine sounding, endometrial sampling (ESP), hysteroscopic and colposcopic interventions, fertility-related procedures (hysterosalpingography, artificial insemination, embryo transfer, etc.) | √ |
√ |
|||||||
| HWY0101 | |
Sialorrhea in patients with neurological disorders and severe chronic drooling problems (e.g., cerebral palsy) | √ |
√ |
|||||||
| HWX0102 | |
Attention Deficit Hyperactivity Disorder (ADHD) | √ |
||||||||
| HWY0301 | |
Atopic Dermatitis; Prurigo Nodularis | √ |
√ |
√ |
√ |
|||||
| HWY0302 | |
Adult patients with Major Depressive Disorder (MDD) who have not achieved satisfactory improvement with at least one prior antidepressant therapy, can be used in home or clinical settings, and is a prescription-only device. | √ |
||||||||
| HWY0303 | |
Mechanical chronic low back pain associated with multifidus muscle dysfunction | √ |
√ |
√ |
||||||
| HWY0304 | |
Patients with spasticity + gait disorders associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury, etc. | √ |
||||||||
| HWY0305 | |
Non-pharmacological treatment of adult Generalized Anxiety Disorder (GAD), as an adjunct to standard anxiety care, for use only by prescription from authorized healthcare professionals. | √ |
||||||||
Address: 28th Floor, Nanyin Building, No. 2 East Third Ring North Road, Chaoyang District, Beijing
Phone: 010-61006202
Personnel recruitment consultation: li-ll@moh-hw.com
Investment and BD cooperation: BD@moh-hw.com
Medical sales consultation: zhang-b@moh-hw.com
Huawei Health Management Group. All Rights Reserved (C) 2021
Powered by PharmNet.com.cn Toocle NetSun Copyright Notice 京ICP备2026038759
Online Drug and Medical Device Information Service Filing: Non-commercial -(京) Online Drug and Device Information Record No. (2026) 00146